The feasibility of amide proton transfer imaging at 3 T for bladder cancer: a preliminary study

Clin Radiol. 2022 Oct;77(10):776-783. doi: 10.1016/j.crad.2022.07.002. Epub 2022 Aug 16.

Abstract

Aim: To investigate the optimal amide proton transfer (APT) imaging parameters for bladder cancer (BCa), the influence of different protein concentrations and pH values on APT imaging, and to establish the reliability of APT imaging in healthy volunteers and patients with BCa.

Materials and methods: The optimal APT imaging parameters for BCa were experimentally optimised using cross-linked bovine serum albumin (BSA) phantoms. BSA phantoms were scanned with different values for the saturation power, saturation duration and number of excitations. Meanwhile, BSA phantoms containing different protein concentrations and solutions of different pH levels were scanned. The interobserver agreement of the asymmetric magnetisation transfer ratio (MTRasym) was assessed in 11 healthy volunteers and 18 patients with BCa.

Results: The optimal scanning scheme consisted of 1 excitation, a saturation power of 2 μT, and a saturation time of 2 s. The APT signal intensity increased as the protein concentration increased and as the pH decreased. The MTRasym showed good concordance for all subjects. The MTRasym of BCa tissue was significantly higher (1.81 ± 0.71) than that of bladder wall in healthy volunteers (0.34 ± 0.12) and normal bladder wall in patients with BCa (0.31 ± 0.11; p<0.001). There was no significant difference between the bladder wall of healthy volunteers and the normal bladder wall of patients with BCa.

Conclusion: APT imaging showed potential value for application in BCa.

MeSH terms

  • Amides / metabolism
  • Dimaprit / analogs & derivatives
  • Feasibility Studies
  • Humans
  • Magnetic Resonance Imaging / methods
  • Protons*
  • Reproducibility of Results
  • Serum Albumin, Bovine
  • Urinary Bladder Neoplasms* / diagnostic imaging

Substances

  • Amides
  • Protons
  • Serum Albumin, Bovine
  • APT
  • Dimaprit